Friday, February 1, 2013- 3 Things to Watch With OPKO Healthat Motley Fool (Fri, Feb 1)
- Update on AGN's Acquisition of MAPZacks (Fri, Feb 1)
- Why Isis Pharmaceuticals Shares Poppedat Motley Fool (Fri, Feb 1)
- What's Ahead for Exelixis?at Motley Fool (Fri, Feb 1)
- Isis: FDA Approval Of Kynamro Promises A Bright Future For Companyat Seeking Alpha (Fri, Feb 1)
- Strong 2012 Results at Novo NordiskZacks (Fri, Feb 1)
- Two Peas in a Pharma Podat Motley Fool (Fri, Feb 1)
- Merck Beats, Issues OutlookZacks (Fri, Feb 1)
- 10 Things You Need To Know This MorningBusiness Insider (Fri, Feb 1)
- Is Opko Health the Perfect Penny Stock?at Motley Fool (Fri, Feb 1)
- Denmark Faces Nokia Moment on $100 Billion Stockat CNBC (Fri, Feb 1)
- Denmark Faces Nokia Moment on $100 Billion Stockat CNBC (Fri, Feb 1)
Thursday, January 31, 2013- Who Will Win This Small Drug Market?at Motley Fool (Thu, Jan 31)
- Sarepta stock slow to recover after Twitter hoaxat bizjournals.com (Thu, Jan 31)
- Mipomersen Approved, Bonus Antisense Roundup Includedat Seeking Alpha (Thu, Jan 31)
- Why Does the Patent Cliff Exist?at Motley Fool (Thu, Jan 31)
- Novo Nordisk Stock Hits High After Q4 Profit Beatat Investor's Business Daily (Thu, Jan 31)
- Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion PharmaceuticalsZacks (Thu, Jan 31)
- What Questcor Investors Absolutely Must Watchat Motley Fool (Thu, Jan 31)
- Flu Season Highlights Demand For Comprehensive Vaccinesat Seeking Alpha (Thu, Jan 31)
Wednesday, January 30, 2013Add SNY News to My Yahoo!   | |
|
0.57 (1.04%) 7:42AM EDT - Nasdaq Real Time Price